Cytomegalovirus (CMV) is a threat to human health in the world, particularly for
immunologically weak patients. CMV may cause opportunistic infections, congenital
infections and central nervous system infections. CMV infections are difficult to treat due to
their specific life cycles, mutation, and latency characteristic. Despite recent advances,
current drugs used for treating active CMV infections are limited in their efficacy, and the
eradication of latent infections is impossible. Current antiviral agents which target the UL54 …